DK154090C - Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof - Google Patents
Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistofInfo
- Publication number
- DK154090C DK154090C DK517180A DK517180A DK154090C DK 154090 C DK154090 C DK 154090C DK 517180 A DK517180 A DK 517180A DK 517180 A DK517180 A DK 517180A DK 154090 C DK154090 C DK 154090C
- Authority
- DK
- Denmark
- Prior art keywords
- monoclonal antibody
- procedure
- cell line
- diagnosis
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Hybrid Cells (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/099,970 US4364933A (en) | 1979-12-04 | 1979-12-04 | Monoclonal antibody to a human thymocyte antigen and methods of preparing same |
US9997079 | 1979-12-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK517180A DK517180A (da) | 1981-06-05 |
DK154090B DK154090B (da) | 1988-10-10 |
DK154090C true DK154090C (da) | 1989-03-06 |
Family
ID=22277479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK517180A DK154090C (da) | 1979-12-04 | 1980-12-03 | Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof |
Country Status (22)
Country | Link |
---|---|
US (1) | US4364933A (es) |
EP (1) | EP0030449B1 (es) |
JP (2) | JPS5695120A (es) |
AT (1) | ATE12660T1 (es) |
AU (1) | AU545222B2 (es) |
CA (1) | CA1181702A (es) |
DE (2) | DE30449T1 (es) |
DK (1) | DK154090C (es) |
ES (1) | ES8303096A1 (es) |
FI (1) | FI75598C (es) |
GR (1) | GR71724B (es) |
HK (1) | HK24286A (es) |
IE (1) | IE50672B1 (es) |
IL (1) | IL61620A (es) |
MY (1) | MY8600516A (es) |
NO (1) | NO159886C (es) |
NZ (1) | NZ195645A (es) |
PH (1) | PH20122A (es) |
PT (1) | PT72144B (es) |
SG (1) | SG7086G (es) |
YU (1) | YU43224B (es) |
ZA (1) | ZA807564B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4582797A (en) * | 1980-09-25 | 1986-04-15 | The Salk Institute For Biological Studies | Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins |
DE3105150A1 (de) * | 1981-02-12 | 1982-08-19 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg | Herstellung von anti-t-lymphozyten-globulin. |
US4434156A (en) | 1981-10-26 | 1984-02-28 | The Salk Institute For Biological Studies | Monoclonal antibodies specific for the human transferrin receptor glycoprotein |
USRE32011E (en) * | 1981-12-14 | 1985-10-22 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
US4443427A (en) * | 1982-06-21 | 1984-04-17 | Sidney Farber Cancer Institute, Inc. | Monoclonal antibody |
US4550086A (en) * | 1983-02-16 | 1985-10-29 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibodies that recognize human T cells |
US4474892A (en) * | 1983-02-16 | 1984-10-02 | Board Of Trustees Of The Leland Stanford Junior University | Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same |
US4579827A (en) * | 1983-03-11 | 1986-04-01 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies |
US4677056A (en) * | 1983-08-18 | 1987-06-30 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibody subsetting human helper and killer T-cells and method |
JPS60231699A (ja) * | 1983-11-09 | 1985-11-18 | Aichiken | 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体 |
US5431897A (en) * | 1985-04-19 | 1995-07-11 | Sloan-Kettering Institute For Cancer Research | Method of imaging colorectal carcinoma lesion and composition for use therein |
US4970299A (en) * | 1986-07-03 | 1990-11-13 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies selective for prostate cancer |
US5601819A (en) * | 1988-08-11 | 1997-02-11 | The General Hospital Corporation | Bispecific antibodies for selective immune regulation and for selective immune cell binding |
CN1068524C (zh) * | 1997-06-23 | 2001-07-18 | 叶庆炜 | 一种治疗顽症牛皮癣的药物 |
US6498006B2 (en) | 1997-11-24 | 2002-12-24 | Johnson T. Wong | Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy |
US7653260B2 (en) | 2004-06-17 | 2010-01-26 | Carl Zeis MicroImaging GmbH | System and method of registering field of view |
US8582924B2 (en) | 2004-06-30 | 2013-11-12 | Carl Zeiss Microimaging Gmbh | Data structure of an image storage and retrieval system |
PE20240589A1 (es) | 2020-10-09 | 2024-03-21 | Pfizer | ANTICUERPOS CD1a Y SU USO |
-
1979
- 1979-12-04 US US06/099,970 patent/US4364933A/en not_active Expired - Lifetime
-
1980
- 1980-11-21 CA CA000365273A patent/CA1181702A/en not_active Expired
- 1980-11-25 NZ NZ195645A patent/NZ195645A/en unknown
- 1980-12-02 AU AU64962/80A patent/AU545222B2/en not_active Expired
- 1980-12-02 GR GR63534A patent/GR71724B/el unknown
- 1980-12-03 NO NO803659A patent/NO159886C/no not_active IP Right Cessation
- 1980-12-03 PH PH24936A patent/PH20122A/en unknown
- 1980-12-03 DE DE198080304347T patent/DE30449T1/de active Pending
- 1980-12-03 DK DK517180A patent/DK154090C/da active
- 1980-12-03 IL IL61620A patent/IL61620A/xx not_active IP Right Cessation
- 1980-12-03 FI FI803755A patent/FI75598C/fi not_active IP Right Cessation
- 1980-12-03 EP EP80304347A patent/EP0030449B1/en not_active Expired
- 1980-12-03 ZA ZA00807564A patent/ZA807564B/xx unknown
- 1980-12-03 ES ES497423A patent/ES8303096A1/es not_active Expired
- 1980-12-03 PT PT72144A patent/PT72144B/pt unknown
- 1980-12-03 IE IE2508/80A patent/IE50672B1/en not_active IP Right Cessation
- 1980-12-03 DE DE8080304347T patent/DE3070479D1/de not_active Expired
- 1980-12-03 YU YU3066/80A patent/YU43224B/xx unknown
- 1980-12-03 AT AT80304347T patent/ATE12660T1/de active
- 1980-12-04 JP JP17032480A patent/JPS5695120A/ja active Granted
-
1986
- 1986-01-23 SG SG70/86A patent/SG7086G/en unknown
- 1986-04-03 HK HK242/86A patent/HK24286A/xx unknown
- 1986-12-30 MY MY516/86A patent/MY8600516A/xx unknown
-
1988
- 1988-05-17 JP JP63118395A patent/JPS6413991A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK153954C (da) | Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof | |
DK154092C (da) | Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof | |
DK154091C (da) | Fremgangsmaade til fremstilling af et monoklonalt antistof samt fremgangsmaade til diagnose hermed og diagnostisk praeparat indeholdende antistoffet | |
DK154087C (da) | Monoklonalt antistof, fremstilling heraf, hybrodimacellelinie til anvendelse ved fremstilling heraf, fremgangsmaade til anvendelse heraf samt diagnostisk praeparat indeholdende antistoffet | |
DK154086C (da) | Monoklonalt antistof, fremstilling deraf, hybridomacellelinie til anvendelse ved fremstilling heraf samt fremgangsmaade til diagnose ved anvendelse heraf | |
DK154769C (da) | Monoklonalt antistof, fremstilling heraf, hybridomacellelinie til anvendelse ved fremstilling heraf samt fremgangsmaader til anvendelse heraf | |
DK154090C (da) | Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof | |
DK154093C (da) | Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt diagnostisk praeparat med det fremstillede monoklonale antistof | |
DK153891C (da) | Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof |